June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Investigating the Connection between Pro-regenerative Inflammation and Wnt-induced Optic Nerve Regeneration
Author Affiliations & Notes
  • Alexander W. Venanzi
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, United States
  • Tal Carmy-Bennun
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Ganesh Musada
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Abigail Hackam
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Alexander Venanzi None; Tal Carmy-Bennun None; Ganesh Musada None; Abigail Hackam None
  • Footnotes
    Support  NEI R01 EY026546 NEI Center Core Grant EY014801
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1566. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexander W. Venanzi, Tal Carmy-Bennun, Ganesh Musada, Abigail Hackam; Investigating the Connection between Pro-regenerative Inflammation and Wnt-induced Optic Nerve Regeneration. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1566.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We recently demonstrated that both canonical and non-canonical Wnt signaling pathways promote axonal growth and RGC survival after optic nerve injury. Retinal microglia have active Wnt signaling, and Wnt3a-induced axonal regeneration is associated with increased microglia, but it is unknown whether Wnt-induced optic nerve regeneration and pro-regenerative inflammation are interrelated. In this study, we investigated whether Wnt-induced axonal regeneration is mediated by neuroinflammation.

Methods : Mice were intravitreally injected with Wnt3a, Wnt5a or saline immediately prior to optic nerve crush (ONC) injury. BV-2 microglia cultures were treated with Wnt3a,Wnt5a, LPS or Saline. QPCR and Western Blot were used to quantify inflammatory molecules. To block inflammation, mice were injected IP with minocycline (45 mg/kg) or water on the day of ONC, then 3x/week for 2.5 weeks. Axonal regeneration was quantified by counting the number of axons at 100 micron intervals past the crush site.

Results : Arg-1, a marker of anti-inflammatory microglia, was 15 times higher in Wnt5a injected retinas compared to saline three days after optic nerve injury (p<0.007) and was 3-fold higher in BV-2 microglia treated with Wnt5a compared to saline (p<0.01). Pro-inflammatory marker of microglia activation Nos2 was twofold higher in Wnt5a treated BV-2 cells compared to control (p<0.007) but was not changed in Wnt5a-injected retinas. Western blots showed a significant increase in key inflammatory regulators, P-JNK (p=0.0007) and P- STAT3 (p<0.0001) in Wnt5a 20ng injected eyes in comparison with PBS injected eyes. In contrast, Wnt3a did not significantly change pro- or anti-inflammatory genes in BV2 cells, while a pro-inflammatory molecule, CCL22 was threefold higher in Wnt3a treated retinas compared to saline (p<0.031). Furthermore, minocycline reduced Wnt3a-induced axonal growth (p=0.042).

Conclusions : This study demonstrated for the first time that Wnt signaling leads to significant changes in both pro- and anti-inflammatory molecules in association with axonal regeneration both in vivo and in vitro. These findings suggest that Wnt5a-induced axonal regeneration is mediated through anti-inflammatory signaling whereas Wnt3a is mediated through pro-inflammatory mediators.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×